CN109432341A - The application of Chinese medicine composition and Chinese materia medica preparation and they - Google Patents
The application of Chinese medicine composition and Chinese materia medica preparation and they Download PDFInfo
- Publication number
- CN109432341A CN109432341A CN201811547266.2A CN201811547266A CN109432341A CN 109432341 A CN109432341 A CN 109432341A CN 201811547266 A CN201811547266 A CN 201811547266A CN 109432341 A CN109432341 A CN 109432341A
- Authority
- CN
- China
- Prior art keywords
- weight
- content
- parts
- medicine composition
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- 239000002398 materia medica Substances 0.000 title claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 34
- 240000000530 Alcea rosea Species 0.000 claims abstract description 17
- 235000017334 Alcea rosea Nutrition 0.000 claims abstract description 16
- 235000017303 Althaea rosea Nutrition 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 27
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 22
- 238000001727 in vivo Methods 0.000 claims description 19
- 230000003860 sleep quality Effects 0.000 claims description 19
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 16
- 241000157352 Uncaria Species 0.000 claims description 16
- 244000144730 Amygdalus persica Species 0.000 claims description 15
- 235000001405 Artemisia annua Nutrition 0.000 claims description 15
- 240000000011 Artemisia annua Species 0.000 claims description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims description 15
- 240000007049 Juglans regia Species 0.000 claims description 15
- 235000009496 Juglans regia Nutrition 0.000 claims description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims description 15
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 15
- 241001199012 Usta Species 0.000 claims description 15
- 239000003864 humus Substances 0.000 claims description 15
- 244000111489 Gardenia augusta Species 0.000 claims description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 14
- 244000046095 Psophocarpus tetragonolobus Species 0.000 claims description 14
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims description 13
- 235000020234 walnut Nutrition 0.000 claims description 13
- 235000014571 nuts Nutrition 0.000 claims description 12
- 239000000470 constituent Substances 0.000 claims description 10
- 230000004060 metabolic process Effects 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000007767 bonding agent Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 34
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 241000758794 Asarum Species 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 3
- 241000804384 Cynomorium songaricum Species 0.000 abstract description 3
- 235000011201 Ginkgo Nutrition 0.000 abstract description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract description 3
- 244000194101 Ginkgo biloba Species 0.000 abstract description 3
- 239000009636 Huang Qi Substances 0.000 abstract description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 3
- 210000003056 antler Anatomy 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 235000008434 ginseng Nutrition 0.000 abstract description 3
- 210000004233 talus Anatomy 0.000 abstract description 3
- 241000208340 Araliaceae Species 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 45
- 230000006872 improvement Effects 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- 230000001225 therapeutic effect Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 235000012907 honey Nutrition 0.000 description 12
- 239000006072 paste Substances 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 230000001151 other effect Effects 0.000 description 11
- 239000006187 pill Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 206010013954 Dysphoria Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 206010013789 Dry throat Diseases 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 206010041497 Spermatorrhoea Diseases 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 108700012359 toxins Proteins 0.000 description 7
- 208000000044 Amnesia Diseases 0.000 description 6
- 208000031091 Amnestic disease Diseases 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 230000006986 amnesia Effects 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 206010015037 epilepsy Diseases 0.000 description 5
- 239000003390 Chinese drug Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010057315 Daydreaming Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000430525 Aurinia saxatilis Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000123069 Ocyurus chrysurus Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000208966 Polygala Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000123747 Uncaria hirsuta Species 0.000 description 2
- 241000214513 Uncaria sinensis Species 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000739 chaotic effect Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000008557 oxygen metabolism Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 235000018648 unbalanced nutrition Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 241000544682 Acorus tatarinowii Species 0.000 description 1
- 241000572565 Alpinia oxyphylla Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000169680 Aphloia theiformis Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019072 Hallucination, olfactory Diseases 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- DQMUQFUTDWISTM-UHFFFAOYSA-N O.[O-2].[Fe+2].[Fe+2].[O-2] Chemical compound O.[O-2].[Fe+2].[Fe+2].[O-2] DQMUQFUTDWISTM-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 241000596297 Photis Species 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241001636762 Polygala sibirica Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000254223 Syntexis Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000123748 Uncaria macrophylla Species 0.000 description 1
- 241000157373 Uncaria rhynchophylla Species 0.000 description 1
- 241000123749 Uncaria sessilifructus Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- -1 corrigent Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- FZFYOUJTOSBFPQ-UHFFFAOYSA-M dipotassium;hydroxide Chemical compound [OH-].[K+].[K+] FZFYOUJTOSBFPQ-UHFFFAOYSA-M 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 231100000405 induce cancer Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004854 plant resin Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000155 toxicity by organ Toxicity 0.000 description 1
- 230000007675 toxicity by organ Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to food and medicine consangunity field of Chinese medicinal composition, disclose the application of a kind of Chinese medicine composition and Chinese materia medica preparation and they, the Chinese medicine composition contains following raw material: hollyhock essence, ginkgo leaf, ginseng, Radix Astragali, semen coicis, pilose antler, triangle vine, cynomorium songaricum, very little rue, complanate astragalus seed, Cortex Cinnamomi, asarum, process rhizoma typhonii, radix glycyrrhizae preparata, wherein, the total weight of the Chinese medicine composition relative to 100 parts by weight, the content of the hollyhock essence is 5-20 parts by weight, ginkgo leaf, ginseng, Radix Astragali, semen coicis, triangle vine, cynomorium songaricum, the content of very little rue is respectively 8-12 parts by weight, the content of pilose antler is 3-8 parts by weight, the content of complanate astragalus seed is 6-10 parts by weight, the content of Cortex Cinnamomi is 0.5-3 parts by weight, the content of asarum is 0.3-0.8 parts by weight, the content for processing rhizoma typhonii is 0.5-3 weight Part, the content of radix glycyrrhizae preparata be 3-8 parts by weight.Chinese materia medica preparation provided by the invention has effects that adjust blood stasis and acidic constitution.
Description
Technical field
The present invention relates to food and medicine consangunity field of Chinese medicinal composition, and in particular to a kind of Chinese medicine composition and its is used in preparation
Improving the drug of sleep quality and substance in vivo dysbolism and/or application in food and one kind with the Chinese medicine composition is
The Chinese materia medica preparation of active constituent and its application in drug of the preparation for improving sleep quality and substance in vivo dysbolism.
Background technique
Obstacle occurs for lipid metaboli in human body, and fatty quantity has exceeded normal range (NR), can be deposited on organ, generates to organ
Toxicity forms injury, leads to serious lipid metaboli disease.Such as cardiovascular and cerebrovascular diseases, diabetes, fatty liver, these extra rouge
Fat is medically known as " rouge poison " to the toxicity of human body.
Oxygen radical can be generated into intracorporal oxygen, oxygen radical is extremely active, flees hither and thither in vivo, attacks and kills
Various cells, lead to the metabolism and dysfunction of cell and organ, and gene mutation can be promoted to induce cancer.Healthy People is in nature
Under state, vivo oxidation and anti-oxidant movement are in dynamic equilibrium.When the accumulation of oxygen poison will lead to human body and generate photis, unreal in human body
It listens, the symptoms such as olfactory hallucination, oral peculiar smell and abnormal feeling.
It is damp and hot poison contain card, be that cold-evil accumulates long, it is strongly fragrant and change heat, it is damp and hot contamination and occur syndrome.It is common in the gangrene of finger or toe.Cold-evil is long
Accumulate, strongly fragrant and change heat, damp and hot contamination then suffers from the red and swollen routed purulence of toe (finger);Pyretic damage of yin can cause fire excess from yin deficiency.The sick deficiency of vital energy positive long cannot resist
Heresy, gangrene, high fever, severe pain continue with the passing of time, to may occur in which body syntexis, burnout out of strength, neurolysis, do not feel like eating, unconsciousness due to high fever
Etc. critical syndrome.Clinical manifestation is suffering limb severe pain, and day at light night is heavy, local swelling, and skin is purple dark, and contamination sprawling, ulceration is rotten, meat
Color is not fresh;The hot dry of body, constipation is urinated red;Tongue is red, yellow and greasy fur, wiry and frequent pulse.
Blood stasis, that is, blood operation is unsmooth, all blood for leaving passages through which vital energy circulates cannot dissipate in time with the stasis of blood it is stagnant in certain or blood flow not
Freely, operation is obstructed, and is pooled within passages through which vital energy circulates or organ in the state of stagnating, is all blood stasis.Blood stasis constitution person is easy to appear silt blueness, face
Color is black, pigmentation easily occur, easily long spot, tongue be dim, body is easy to happen the easy bleeding of pain, gum;It is shown as in psychological aspects
It is easy agitation, is also easy to the symptoms such as amnesia occur.When various toxin, waste will cause metabolic disorder because blood stasis retains in vivo,
Hinder qi and blood operate normally, destroy internal organs function and internal organs it is dirty between it is mutually coordinated.
Chinese medicine thinks to reduce the generations of toxins in human body such as internal rouge is malicious, oxygen is malicious, chill is damp and hot, keeps gas row healthy and vigorous and blood
Row is unimpeded, adjusts lining qi and blood balance, and the colour of skin could be full ruddy, and people are just able to maintain energetic, and body and mind is happy, and physique is strong
It is strong, it prolongs life.
There are many medicament categories of sleep quality and substance in vivo dysbolism and dosage form is various for improving currently on the market,
Although certain effect can be played, there are still eating, medicine decocting time is long, not portable, unbalanced nutrition, is unfavorable for inhaling
The problems such as receipts and holding time are short.
Summary of the invention
The purpose of the invention is to overcome the drug for being currently used for improving sleep quality and substance in vivo dysbolism to deposit
Medicine decocting time is long, not portable, unbalanced nutrition, is unfavorable for absorbing and the defects of the holding time is short, provides one kind and have both eating
It is convenient to take, portable, nutrition is balanced, conducive to absorb and the holding time it is long the advantages that Chinese medicine composition and its preparation for improving
The drug of sleep quality and substance in vivo dysbolism and/or application in food and it is a kind of with the Chinese medicine composition be activity
The Chinese materia medica preparation of ingredient and its application in drug of the preparation for improving sleep quality and substance in vivo dysbolism.
To achieve the goals above, one aspect of the present invention provides a kind of Chinese medicine composition, which contains following
Raw material: hollyhock essence, black hyacinth bean, uncaria, Rhizoma Gastrodiae, peach kernel, safflower, fushen, Radix Polygalae, amber, rhizoma acori graminei, goldleaf, fructus alpiniae oxyphyllae, wild jujube
Benevolence, fructus schisandrae, lotus nut, walnut kernel, cape jasmine, sweet wormwood, humus flava usta, Radix Glycyrrhizae, wherein the Chinese medicine relative to 100 parts by weight
The total weight of composition, the content of the hollyhock essence is 3-15 parts by weight, the content of black hyacinth bean is that 3-15 parts by weight, uncaria contain
Amount is 3-15 parts by weight, the content of Rhizoma Gastrodiae is 2-12 parts by weight, the content of peach kernel is 2-12 parts by weight, the content of safflower is 2-12
Parts by weight, the content of fushen are 2-12 parts by weight, the content of Radix Polygalae is 2-10 parts by weight, the content of amber be 2-10 parts by weight,
The content of rhizoma acori graminei is 0.5-8 parts by weight, the content of goldleaf is 0.01-0.05 parts by weight, the content of fructus alpiniae oxyphyllae is 2-10 weight
Part, the content of semen ziziphi spinosae be 2-10 parts by weight, the content of fructus schisandrae is 2-10 parts by weight, the content of lotus nut is 2-10 weight
Part, the content of walnut kernel be 2-10 parts by weight, the content of cape jasmine is 0.5-7 parts by weight, the content of sweet wormwood be 0.3-6 parts by weight,
The content of humus flava usta is 0.5-7 parts by weight, the content of Radix Glycyrrhizae is 0.3-6 parts by weight.
Second aspect of the present invention provides above-mentioned Chinese medicine composition in preparation for improving sleep quality and substance in vivo metabolism
Application in the drug of obstacle.
Third aspect present invention provides above-mentioned Chinese medicine composition in preparation for improving sleep quality and substance in vivo metabolism
Application in the food of obstacle.
Fourth aspect present invention provides a kind of Chinese materia medica preparation, which contains active constituent and auxiliary material, wherein described
Active constituent is aforementioned Chinese medicine composition.
Fifth aspect present invention provides a kind of aforementioned Chinese materia medica preparation in preparation for improving sleep quality and substance in vivo generation
Thank to the application in the drug of obstacle.
Chinese medicine composition and Chinese drugs agentia provided by the invention have it is convenient to take, portable, nutrition is balanced, be conducive to absorb and
The advantages that holding time is long can be effectively improved sleep quality and substance in vivo dysbolism.
Other features and advantages of the present invention will the following detailed description will be given in the detailed implementation section.
Specific embodiment
The endpoint of disclosed range and any value are not limited to the accurate range or value herein, these ranges or
Value should be understood as comprising the value close to these ranges or value.For numberical range, between the endpoint value of each range, respectively
It can be combined with each other between the endpoint value of a range and individual point value, and individually between point value and obtain one or more
New numberical range, these numberical ranges should be considered as specific open herein.
As previously mentioned, first aspect present invention provides a kind of Chinese medicine composition, which contains following raw material: another name for Sichuan Province
Certain herbaceous plants with big flowers essence, black hyacinth bean, uncaria, Rhizoma Gastrodiae, peach kernel, safflower, fushen, Radix Polygalae, amber, rhizoma acori graminei, goldleaf, fructus alpiniae oxyphyllae, semen ziziphi spinosae, north five
Taste, lotus nut, walnut kernel, humus flava usta, cape jasmine, sweet wormwood, Radix Glycyrrhizae, wherein the Chinese medicine composition relative to 100 parts by weight
Total weight, the content of the hollyhock essence is 3-15 parts by weight, the content of black hyacinth bean is 3-15 parts by weight, the content of uncaria is 3-15
Parts by weight, the content of Rhizoma Gastrodiae are 2-12 parts by weight, the content of peach kernel is 2-12 parts by weight, the content of safflower be 2-12 parts by weight,
The content of fushen is 2-12 parts by weight, the content of Radix Polygalae is 2-10 parts by weight, the content of amber is 2-10 parts by weight, rhizoma acori graminei
Content is 0.5-8 parts by weight, the content of goldleaf is 0.01-0.05 parts by weight, the content of fructus alpiniae oxyphyllae is 2-10 parts by weight, semen ziziphi spinosae
Content be 2-10 parts by weight, the content of fructus schisandrae is 2-10 parts by weight, the content of lotus nut is 2-10 parts by weight, walnut kernel
Content is 2-10 parts by weight, the content of cape jasmine is 0.5-7 parts by weight, the content of sweet wormwood is 0.3-6 parts by weight, the content of humus flava usta
It is 0.3-6 parts by weight for 0.5-7 parts by weight, the content of Radix Glycyrrhizae.
Under preferable case, the content of the total weight of the Chinese medicine composition relative to 100 parts by weight, the hollyhock essence is
5-12 parts by weight, the content of black hyacinth bean are 5-12 parts by weight, the content of uncaria is 5-12 parts by weight, the content of Rhizoma Gastrodiae is 3-10 weight
Measure part, the content of peach kernel is 3-10 parts by weight, the content of safflower is 3-10 parts by weight, the content of fushen is 3-10 parts by weight, remote
The content of will is 3-8 parts by weight, the content of amber is 3-8 parts by weight, the content of rhizoma acori graminei is that 1-5.5 parts by weight, goldleaf contain
Amount is 0.01-0.03 parts by weight, the content of fructus alpiniae oxyphyllae is 3-8 parts by weight, the content of semen ziziphi spinosae is 3-8 parts by weight, fructus schisandrae
Content be 3-8 parts by weight, the content of lotus nut is 3-8 parts by weight, the content of walnut kernel is 3-8 parts by weight, the content of cape jasmine is
1-5 parts by weight, the content of sweet wormwood are 0.5-4 parts by weight, the content of humus flava usta is 1-5 parts by weight, the content of Radix Glycyrrhizae is 0.5-4 weight
Measure part.
A kind of preferred embodiment according to the present invention, the total weight of the Chinese medicine composition relative to 100 parts by weight,
The content of the hollyhock essence is 8 parts by weight, the content of black hyacinth bean is 8 parts by weight, the content of uncaria is that 8 parts by weight, Rhizoma Gastrodiae contain
Amount is 6 parts by weight, the content of peach kernel is 6 parts by weight, the content of safflower is 6 parts by weight, the content of fushen is 6 parts by weight, Radix Polygalae
Content be 5.5 parts by weight, the content of amber is 5.5 parts by weight, the content of rhizoma acori graminei is 4.5 parts by weight, the content of goldleaf is
0.04 parts by weight, the content of fructus alpiniae oxyphyllae are 5.5 parts by weight, the content of semen ziziphi spinosae is 5.5 parts by weight, the content of fructus schisandrae is
5.5 parts by weight, the content of lotus nut are 5.5 parts by weight, the content of walnut kernel is 5.5 parts by weight, the content of cape jasmine is 2.7 weight
Part, the content of sweet wormwood be 1.8 parts by weight, the content of humus flava usta is 2.7 parts by weight, the content of Radix Glycyrrhizae is 1.8 parts by weight.
According to the present invention, the pharmacological action of each bulk pharmaceutical chemicals of the Chinese medicine composition and side's solution are as follows:
The hollyhock essence is root, leaf, flower and the kind of Malvaceae hollyhock platymiscium hollyhock (Althaearosea (L.) Cavan)
At least one of son.With treating stranguria, the effect of detumescence, removing toxic substances, it is usually used in controlling stranguria syndrome, swollen ulcer drug, the burning hot wound of soup.
The black hyacinth bean is the leaf and kind of dicotyledon medicine leguminous plant Dolichos lablab (DolichoscultatusThunb.)
Son, sweet in flavor, tepor.Enter spleen, stomach meridian.Has effects that invigorating spleen, dampness elimination of relieving summer heat, to summer-heat and damp is vomited and diarrhoea, spleen deficiency is vomitted, and inverse, deficiency of food is long
It lets out, the symptoms such as water stops quenching one's thirst, leukorrhea with reddish discharge and infantile malnutrition have significant improvement result.
The uncaria is madder wort uncaria (Uncariarhynchophylla (Miq.) Miq.exHavil), great Ye
Uncaria (Uncariamacrophylla Wall.), uncaria hirsuta (UncariahirsutaHavil.), Uncaria sinensis
In (Uncariasinensis (Oliv.) Havil.) and stockless fruit uncaria (UncariasessilifructusRoxb.) extremely
A kind of few drying buckle stem branch, sweet-bitter flavor;Cold nature.Have effects that The flat liver of heat-clearing, relieving convulsion and spasm, calm decompression, for
The symptoms such as headache and dizziness, dysphoric cold, twitch, pre-eclampsia and hypertension have significant improvement result.
The Rhizoma Gastrodiae is the dry tuber of orchid Rhizoma Gastrodiae (GastrodiaelataBlume), sweet in flavor, mild-natured.Have
The effect of calming the liver to stop the wind, relieving convulsion.Have for symptoms such as headache and dizziness, extremity numbness, child convulsion, epilepsy clonus and tetanus
Significant improvement result.
The peach kernel is rosaceous plant peach (Prunuspersica (L.) Batsch) or mountain peach (Prunusdavidiana
(Carr.) Franch.) dry mature seed, it is bitter, sweet, it is mild-natured;Enter the heart, liver, large intestine channel.It is logical with activating blood circulation and dissipating phlegm, ease constipation
Just the effect of.Have for symptoms such as amenorrhea and algomenorrhea, lump in the abdomen lump in the abdomen lump in the abdomen, pulmonary abscess acute appendicitis, injury from falling down and dry constipation of intestines asthmas significant
Improvement result.
The safflower is the dry flower of compositae plant safflower (Carthamustinctorius L.), and acrid flavour is warm-natured.Have
The effect of blood circulation, removing blood stasis and acesodyne.For menostasis, dysmenorrhea, lochia, abdominal mass lump in the abdomen, chest impediment and cardialgia, stasis of blood, chest
Coercing the symptoms such as shouting pain, injury from falling down and sore swell and ache curative has significant improvement result.
The hollyhock essence, black hyacinth bean, uncaria, Rhizoma Gastrodiae, peach kernel and safflower are monarch drug in a prescription altogether, and above-mentioned six kinds of substances are with use appropriate
Amount can play the role of clearing heat and detoxicating, nourishing yin and purging fire, tranquilizing and allaying excitement than being used cooperatively.
Fushen's Polyporaceae crouch hole platymiscium Poria cocos (Poria cum Radix Pini) dry sclerotia body among
Entertain the white portion of pine stump, it is sweet in flavor, light flat.With excreting dampness, invigorating the spleen, calming heart and other effects.For palpitation with fear of having a guilty conscience, amnesia, insomnia,
The symptoms such as frightened epilepsy, difficult urination have significant improvement result.
The Radix Polygalae is Polygalaceae polygala Radix Polygalae (Polygala tenuifoliaWilld) or ovum leaf Radix Polygalae
The dry root of (Polygala sibirica L.), it is bitter, pungent, it is warm-natured.With tranquilize the mind and promote the intelligence, eliminating the phlegm, detumescence and other effects.For
The symptoms tool such as insomnia and dreamful sleep caused by breakdown of the normal physiological coordination between the heart and the kidney, amnesia and pavor, despicable, expectoration is not well, sore swollen toxin and breast swell and pain
It is significantly improved effect.
The amber be ancient times pinaceae plant resin burial ground under hydrocarbon made of prolonged condensation, slightly sweet flavor,
It is mild-natured.Enter the heart, liver, small intestinl channel.With tranquillizing the mind by relieving convulsion, dissipating stasis and stanching bleeding, promoting diuresis for stranguria and other effects.Infantile convulsion epilepsy, palpitation with fear are lost
Dormancy, blood strangury blood urine, urinary obstruction, women's amenorrhoea, postpartum stop the symptoms such as stasis of blood abdominal pain, skin sore and traumatic injuries with significant
Improvement result.
The rhizoma acori graminei is the dry rhizome of acorus gramineus araceae plant (Acorustatarinowii Schott), taste
It is pungent, bitter, it is warm-natured.Return heart, stomach meridian.With dampness elimination appetizing, slit phlegm of having one's ideas straightened out, inducing resuscitation intelligence development and other effects.For gastral cavity ruffian is not hungry, keep silent under mouth
Dysentery, coma epilepsy, which are changed, has significant improvement result with symptoms such as forgetfulness and deafness.
The goldleaf is the paper-like thin slice of gold hammer out, and the original shape state of the gold can be rusty gold, the rusty gold
It is generally divided into lode gold (mountain gold) and two kinds of gold dust, lode gold originates in quartz vein, and gold dust originates in alluvium.The goldleaf is arduous,
It is mild-natured.With relieving palpitation, tranquilizing the mind, removing toxic substances and other effects.Work is significantly improved for the symptoms such as frightened epilepsy, demented, palpitaition and sore tool
With.
The fruit of the fructus alpiniae oxyphyllae zingiberaceous plant intelligence development (AlpiniaoxyphyllaMiq.), acrid flavour, warm-natured spleen.Kidney channel.
Saliva, warm kidney astringent sperm contracting urine and other effects are taken the photograph with warming spleen and stopping diarrha.For crymodynia in malaria diarrhea, abdomen, the more salivas of mouth, enuresis with renal asthenia,
The symptoms such as frequent urination and spermatorrhea gonorrhoea have significant improvement result.
Above-mentioned fushen, Radix Polygalae, amber, rhizoma acori graminei, goldleaf, six medicine of fructus alpiniae oxyphyllae share as ministerial drug, for assisting monarch drug in a prescription to reinforce
Treat main disease or main symptom or for and disease or accompanying symptoms play therapeutic effect, six with amount ratio appropriate with the use of can be into one
Step reinforces the effect of clearing heat and detoxicating, nourishing yin and purging fire, mental-tranquilization.
The semen ziziphi spinosae is rhamnaceae plant wild jujube (ZiziphusjujubaMill.var.spinosa (Bunge) Hu ex
H.F.Chou dry mature seed), it is sweet in flavor, sour, it is mild-natured;Return liver, gallbladder, the heart channel of Hang-Shaoyin.With nourishing heart tonifying liver, antitoxic heart-soothing and sedative, arrest sweating,
Promote the production of body fluid and other effects.There is significant improvement result for symptoms such as neurasthenia, insomnia, dreaminess and night sweat.
The fructus schisandrae is the perennial fallen leaves bejuco Schisandra chinensis (Schisandrachinesis of Magnoliaceae
(Turcz.) Baill) dry mature fruit, it is sour, it is warm-natured.Enter lung, kidney channel.With astringing lung-QI nourshing kidney, only saliva hidroschesis, arresting seminal emission are stopped
The effect of rushing down, calming the nerves.Work is significantly improved for the symptoms such as empty cough asthma, Diarrhoea, night sweat due to yin deficiency and insomnia forgetfulness tool
With.
The lotus nut be spire in the mature seed of nymphaeaceae plant lotus (NelumbonuciferaGaertn.) and
Radicle, bitter are cold in nature.Enter the heart, lung, kidney three to pass through.With clear away heart-fire be amusing, tonifying spleen and stopping diarrhea, mental-tranquilization improving eyesight, bowl spares are reposed, are good for
Spleen mends stomach, antidiarrheal controlling nocturnal emission with astringent drugs, kidney-nourishing relieving leukorrhea by astringents, nourishing vigour and other effects.For the invasion of pericardium by heat, coma and delirium, breakdown of the normal physiological coordination between the heart and the kidney, mistake
The symptoms such as spermatorrhea and blood-head haematemesis of sleeping have significant improvement result.
The walnut kernel is the seed of juglandaceae plant English walnut (Juglansregia), sweet in flavor, warm-natured;Enter lung, kidney channel.Tool
There are temperature compensation lung kidney, Dingchuan ease constipation and other effects.For lumbago due to the kidney deficiency, foot is soft, the cold of insufficiency type is breathed with cough have with symptoms such as dry feces it is significant
Improvement result.
The cape jasmine is the fruit of madder wort cape jasmine (Gardenia jasminoides Ellis), bitter, cold in nature.
Enter the heart, liver, lung, stomach, tri-jiao channel.The cold energy heat-clearing of the cape jasmine, bitter energy eliminating dampness, body gently enter gas, color red blood, under capable of reaching on
Have a thorough knowledge of three cokes, and it is hot and suffocating to be apt to clear chest diaphragm.With purging intense heat relieving restlessness, reducing fever and causing diuresis and removing pattogenic heat from the blood and toxic material from the body and other effects.For icteric hepatitis,
The symptoms such as bruise, hypertension, diabetes have significant improvement result.
The sweet wormwood is the dry aerial parts of compositae plant artemisia annua (Artemisia annua L.), bitter, pungent, property
It is cold.Return liver, gallbladder channel, three burnt, kidney channels.With clear abnormal heat, cool blood except steaming, relieving summer-heat and preventing malaria and other effects.For warm evil impairment of yin, night
The symptoms such as hot early cool, fever due to yin deficiency, hectic fever due to yin labor heat, summer-heat evil fever, malaria fever and chills and jaundice with damp-heat pathogen have significant improvement result.
Above-mentioned semen ziziphi spinosae, fructus schisandrae, lotus nut, walnut kernel, cape jasmine, six medicine of sweet wormwood share as adjutant, for assisting monarch, minister
Medicine is to reinforce therapeutic effect, or directly treats secondary accompanying symptoms, and restrict monarch, ministerial drug high strong property, or be mitigated or eliminated monarch,
The drug of ministerial drug toxicity, at the same can also according to the need of certain diseases, compatibility on a small quantity with monarch drug in a prescription nature and flavor or the opposite and energy of effect
Serve in the treatment and coordinates.
The humus flava usta is the sallow soil block for burning the Tu Zaonei bottom centre of firewood or weeds, is overhauling firewood furnace or firewood
When fiery, the soil block of sintering is removed, prunes burned black part and impurity also known as humus flava usta with knife.It mainly include silicic acid
(H2SiO3), aluminium oxide (Al2O3) and di-iron trioxide (Fe2O3) ingredient, also contain sodium oxide molybdena (Na2O), potassium oxide (K2O), oxygen
Change magnesium (MgO), calcium oxide (CaO) and calcium phosphate [Ca3(PO4)2] etc. ingredients.The humus flava usta acrid flavour, slightly warm in nature.Enter spleen, stomach
Through.Astringing to arrest bleeding, warming middle energizer to arrest vomiting.
Above-mentioned humus flava usta is to make medicine, can be used as harmonizing drug, is used for coordinating the drug actions of a prescription, priming channel tropism.
The Radix Glycyrrhizae is glycyrrhizic legume (GlycyrrhizauralensisFisch.), swollen fruit Radix
The dry root and rhizome of (Glycyrrhizainflata Bat.) or glycyrrhiza glabra (Glycyrrhizaglabra L.), sweet in flavor,
It is mild-natured.Return heart enters lung, spleen, stomach meridian.Have effects that tonifying spleen stomach function regulating, Yiqi and vein recovery.In addition, the Radix Glycyrrhizae has priming channel tropism
Function, the efficacy of a drug of other medicines can be guided to reach diseased region or a certain passages through which vital energy circulates, play the role of " guide ".
Above-mentioned various raw materials can buy the product cooked on the market, can also be obtained by conventional concocting method
It arrives, such as can be made and being dried and being ground into powder commonly used in the art for raw material.Dry method can be
Drying is dried naturally, is preferably dried naturally.The method of grinding can for the field of Chinese medicines it is conventional by Chinese medicine grind into powder
Method, the condition of grinding preferably makes the average particle size 150-200 mesh of the raw material, more preferably 160-180 mesh.
Chinese medicine composition provided by the invention can be made by mixing the various raw materials.As long as mixed condition
It is uniformly mixed various raw materials.
Chinese medicine composition provided by the invention contain acetylcholine, lecithin, sodium succinate, flavones, low sugar, protein,
The ingredients such as low fat, microelement, multi-vitamins and cellulose can when each raw material component is used cooperatively at a specific ratio
To confused and worried, unwisely, vivotoxin accumulation, dysphoria and insomnia, palpitation and amnesia, dizziness and tinnitus, soreness of waist spermatorrhea, five vexed
The symptoms such as heat, dry throat generate good improvement result, especially suitable for refreshment and tranquilization, promote blood oxygen metabolism, improve sleep
Quality and the content for reducing toxin caused by the intracorporal rouge poison of people, oxygen poison, the damp and hot malicious and intense strain of chill.
The present invention also provides a kind of aforementioned Chinese medicine composition in preparation for improving sleep quality and substance in vivo metabolism
Application in the drug of obstacle.
The present invention also provides a kind of aforementioned Chinese medicine composition in preparation for improving sleep quality and substance in vivo metabolism
Application in the food of obstacle.
The present invention also provides a kind of Chinese materia medica preparation, which contains active constituent and auxiliary material, wherein the activity
Ingredient is Chinese medicine composition provided by the invention.
The Chinese materia medica preparation provided according to the present invention, on the basis of the total weight of the Chinese materia medica preparation, the active constituent contains
Amount can be 10-90 weight %, and the content of the auxiliary material can be 10-90 weight %.Under preferable case, the active constituent
Content is 40-60 weight %, and the content of the auxiliary material is 40-60 weight %.
The Chinese materia medica preparation provided according to the present invention can be mixture, pill, particle, syrup, paste, capsule and tablet
One of.
The Chinese materia medica preparation provided according to the present invention, the auxiliary material can be common pharmaceutically acceptable auxiliary for Chinese materia medica preparation
Material, such as can be at least one of pharmaceutically acceptable carrier, diluent, filler and bonding agent.The carrier includes
But it is not limited to starch or derivatives thereof, lactose, polyethylene glycol;The diluent includes but is not limited to starch or derivatives thereof, cream
Sugar, sucrose, vegetable oil, wax, fatty acid;Filler includes but is not limited to talcum powder;The auxiliary material can also include as preservative,
In lubricant, dispersing agent, corrigent, moisturizer, antioxidant, colorant, stabilizer, buffer and pH adjusting agent at least
It is a kind of.
The auxiliary material can also include binder, filler, disintegrating agent, lubricant in other excipient, such as tablet;
Wine, vinegar, decoction in medicine pill etc.;Host material in semi-solid preparation ointment, creme;Anti-corrosion in liquid preparation
Agent, antioxidant, corrigent, aromatic, cosolvent, emulsifier, solubilizer, osmotic pressure regulator, colorant etc..The auxiliary material structure
At drug or antigen, it is inactive substance (such as Arabic gum, syrup, honey, lanolin or starch);Espespecially in medicinal mixture
In have under sufficient amount liquid case, to make mixture toughness, the substance that is added to prepare pill or tablet.Above-mentioned substance
The stability being formulated is helped as needed or is helped to improve activity or biological effectiveness or is generated and can connect in the case where oral
The mouthfeel or smell received.
A kind of preferred embodiment according to the present invention, when the Chinese materia medica preparation is pill or paste, the auxiliary material is
At least one of starch, rye flour and honey.In further preferred situation, the auxiliary material is that weight ratio is 0-10: 100
Starch and honey.
According to the present invention, when the Chinese materia medica preparation be pill when, the preparation method of the pill may include by activity at
Divide and auxiliary material mixes, then forms.The mixed temperature can be 100-130 DEG C, preferably 105-110 DEG C, when mixed
Between can be 10-60 minutes.The molding method can be using the conventional forming method for being used to prepare pill, such as can be with
The Traditional Chinese drug mixture being mixed to form is put into pelletization in pellet processing machine.
According to the present invention, when the Chinese materia medica preparation be paste when, the preparation method of the paste may include by activity at
Divide and auxiliary material mixes, then forms.The mixed temperature can be 100-130 DEG C, preferably 105-110 DEG C, when mixed
Between can be 10-30 minutes.The molding method can be using the conventional forming method for being used to prepare paste, such as can be with
The Traditional Chinese drug mixture being mixed to form is put into Manufacturing medicine extract machine, paste is made.
According to the present invention, when the Chinese materia medica preparation be tablet when, the preparation method of the tablet may include by activity at
Divide and auxiliary material mixes, then forms.The mixed temperature can be 100-130 DEG C, preferably 105-110 DEG C, when mixed
Between can be 10-30 minutes.The molding method can be using the conventional forming method for being used to prepare tablet, such as can be with
The Traditional Chinese drug mixture being mixed to form is put into pelleter in flakes.
According to the present invention, when the Chinese materia medica preparation be mixture when, the preparation method of the mixture may include by activity at
Divide and auxiliary material mixes, then successively extracts effective component, concentration and purification process.
According to the present invention it is possible to such as be decocted using various conventional traditional Chinese medicine extyaction methods come effective component extracting
Cooking method, water extraction and alcohol precipitation method, salting out method and organic solvent extraction etc., since said extracted method can obtain aforementioned Chinese medicine preparation
In main pharmacodynamics ingredient, therefore can have refreshment and tranquilization, promote blood oxygen metabolism, improve sleep quality and reduce human body in
Rouge poison, oxygen poison, chill it is damp and hot poison and intense strain caused by toxin content the effect of, to confused and worried, unwisely, internal
The symptoms such as toxin accumulation, dysphoria and insomnia, palpitation and amnesia, dizziness and tinnitus, soreness of waist spermatorrhea, dysphoria in chestpalms-soles, dry throat have certain
Curative effect.
According to the present invention, the water extraction and alcohol precipitation method may include: and first take water as a solvent to extract medicinal material effective component, then with not
Ethyl alcohol with concentration uses the precipitation method to remove the impurity in extracting solution.When being extracted with water, the weight ratio of medicinal material and water can be 1
: 6-10 extracts 1-3 times and combined extract.When being precipitated with alcohol, the aqueous extract of every gram of medicinal material can be 65-80 with 1mL concentration
The ethyl alcohol of weight % is precipitated.In general, using the primary water-soluble in the extractable medicinal material out of water extraction and alcohol precipitation method being more than 70%
Active constituent.
According to the present invention, the organic solvent extraction may include: commonly used with ethyl acetate, acetic acid, triethylamine etc. it is molten
After agent and ethyl alcohol or water are mixed in a certain ratio, the specific effective component in medicinal material is targetedly extracted.By organic molten
The extractable higher specific effective component of purity out of agent extraction method.
According to the present invention, again through conventional step concentration, purifying or drying after the Chinese medicine composition effective component extracting
Obtain Chinese medical extract.The method being wherein concentrated includes but is not limited to: atmospheric evaporation, reduction vaporization, thin film evaporation, multiple-effect are steamed
Hair, the method for purifying includes but is not limited to: method of purification of saltouing, macroporous resin adsorption method of purification, ethanol precipitation method of purification, ion effect
Purifying resin method, flocculation sedimentation method of purification, membrane separating and purifying method, polycaprolactam method of purification, silica gel absorption chromatographic purifying etc. are changed,
Dry method includes but is not limited to: oven drying method, drum-type seasoning, belt drying method, hygroscopic desiccation method, fluid-bed drying, spray
Mist seasoning, hypobaric drying method, freeze-drying, infrared drying, micro-wave drying method etc..
According to the present invention, according to the characteristic of crude drug effective components different in the Chinese medicine composition, different mention can be used
Taking technique.
Preferably, each Chinese medicine material of the invention is first processed before extraction, wherein to hollyhock essence, ginkgo leaf, people
Ginseng, Radix Astragali, semen coicis, pilose antler, triangle vine, cynomorium songaricum, very little rue, complanate astragalus seed, Cortex Cinnamomi and asarum honey refine laggard leaching of serving a round of liquor to the guests;It is white attached to processing
Son and radix glycyrrhizae preparata, which are placed in small fire, to be propagandized hotly 30-60 minutes.
The present invention also provides a kind of aforementioned Chinese materia medica preparation in preparation for improving sleep quality and substance in vivo metabolism barrier
The application in drug hindered.
Chinese materia medica preparation provided by the invention has effects that promote substance in vivo metabolism, to confused and worried, unwisely, internal
The symptoms such as toxin accumulation, dysphoria and insomnia, palpitation and amnesia, dizziness and tinnitus, soreness of waist spermatorrhea, dysphoria in chestpalms-soles and dry throat, which have, significantly to be changed
Kind effect.
Below by embodiment, the present invention will be described in more detail.
The processing method of raw material used in following embodiment is as follows:
Respectively by hollyhock essence, black hyacinth bean, uncaria, Rhizoma Gastrodiae, peach kernel, safflower, fushen, Radix Polygalae, amber, rhizoma acori graminei, goldleaf, benefit
Intelligence benevolence, semen ziziphi spinosae, fructus schisandrae, lotus nut, walnut kernel, humus flava usta, cape jasmine, sweet wormwood and Radix Glycyrrhizae are ground to 180 purposes after drying
Powder.
Wherein, the specification of every goldleaf is 9.33cm × 9.33cm × 0.12 μm (length × width x thickness), specific gravity 15.6-
18.3, weight 0.02g.
Embodiment 1-5
Embodiment 1-5 is used to prepare the present invention and provides the Chinese medicine composition of object.
Each raw material is mixed according to dosage shown in table 1, composition A1-A5 is made respectively.
Table 1
Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | |
Chinese medicine composition number | A1 | A2 | A3 | A4 | A5 |
Hollyhock essence | 14.5g | 18.5g | 11g | 6g | 23g |
Black hyacinth bean | 14.5g | 10.5g | 18g | 23g | 6g |
Uncaria | 14.5g | 16.5g | 14.5g | 8.5g | 20.5g |
Rhizoma Gastrodiae | 11g | 9g | 11g | 20g | 5g |
Peach kernel | 11g | 9g | 11g | 5g | 20g |
Safflower | 11g | 11g | 9g | 5g | 5g |
Fushen | 11g | 16g | 14g | 18g | 10g |
Radix Polygalae | 10g | 8g | 11g | 5g | 15g |
Amber | 10g | 9g | 9g | 15g | 5g |
Rhizoma acori graminei | 8g | 6g | 6g | 4g | 5g |
Goldleaf | 2 | 1 | 3 | 2 | 2 |
Fructus alpiniae oxyphyllae | 10g | 11g | 9g | 15g | 5g |
Semen ziziphi spinosae | 10g | 11g | 10g | 5g | 15g |
Fructus schisandrae | 10g | 8g | 9g | 11g | 5g |
Lotus core | 10g | 9g | 11g | 8g | 12g |
Walnut kernel | 10g | 11g | 8g | 8g | 13g |
Cape jasmine | 4.75g | 5.75g | 5.25g | 10g | 1g |
Sweet wormwood | 3g | 3g | 4.5g | 0.5g | 8g |
Humus flava usta | 4.75g | 5.75g | 5.25g | 10g | 1.5g |
Radix Glycyrrhizae | 3g | 3g | 4.5g | 4g | 6g |
Embodiment 6-10
Embodiment 6-10 is used to prepare the pill in Chinese materia medica preparation provided by the invention.
Will starch and honey by weight being heated to 110 DEG C after 1: 10 mixing, then respectively prepared by embodiment 1-5
Drug composition A1-A5 is added in the mixture of starch and honey (wherein, the weight of the mixture of A1-A3 and starch and honey
It is 2 than the weight ratio for 1: 4, A4-A5 and the mixture of starch and honey: 1), is boiled 20 minutes at 110 DEG C.Then natural
It is cooled to after room temperature to be added in pellet processing machine and ball is made, the weight of every ball is 181 grams to get pill B1-B5.
Embodiment 11-15
Embodiment 11-15 is used to prepare the paste in Chinese materia medica preparation provided by the invention.
Honey is heated to 110 DEG C, Chinese medicine composition A1-A5 prepared by exemplified 1-5 is then added to honey respectively
In (wherein, the weight ratio of A1-A3 and honey is 1: 9, A4-A5 and the weight ratio of honey is 7: 1), and 20 points of the tanning at 110 DEG C
Clock.It is then added to and impartial fritter is made in Manufacturing medicine extract machine.Every piece of weight is 181 grams to get paste C1-C5.
Experimental example 1-5
Experimental example 1-5 is used to illustrate the effect of Chinese materia medica preparation provided by the invention.
(1) absent-minded, attention can not be concentrated, melancholy does not determine, haves the fidgets, speech logic is chaotic, narration is unclear
Patient (physical examination: look indefinite, it is absent-minded, have the fidgets, ask non-answered;Tongue fur: micro- Huang, arteries and veins: heavy, thin, slow, puckery) control
Therapeutic effect
Selection 400 with absent-minded, attention can not be concentrated, melancholy does not determine, haves the fidgets, voice is patrolled in various degree
16-65 years old patient for collecting symptom chaotic, that narration is unclear, is randomly divided into 10 treatment groups (every group of 40 patients).Wherein, 5
Pill B1-B5 takes respectively in treatment group, and instructions of taking is once in the morning and once at night 1 ball every time, and boiled water is oral, when taking one section
Between after observing effect, compared with before medication, the label that symptom completely disappears is that the substantially reduced label of symptom is symptom
The label being not improved is that the therapeutic effect of 5 treatment groups is as shown in table 1-3;Paste is taken respectively by other 5 treatment groups
C1-C5, instructions of taking are once in the morning and once at night one piece every time, and boiled water is oral, observing effect after a period of time is taken, with clothes
Compared before medicine, the label that symptom completely disappears is, the substantially reduced label of symptom is, the label that symptom is not improved be
×, the therapeutic effect of 5 treatment groups is as shown in Table 2-4.
Table 2 takes effect after 15 days
Table 3 takes effect after 30 days
Table 4 takes effect after 60 days
(2) the aching and tired therapeutic effect felt cold of waist lower limb is shown in soreness of waist spermatorrhea, companion
Selection 250 have the spermatorrhea of the different degrees of soreness of waist, with see waist lower limb it is aching and tired feel cold (physical examination: tongue is red, whitish tongue or
It is greasy, rapid pulse is thin) 20-60 years old male patient, be randomly divided into 10 treatment groups (every group of 25 patients).Wherein, 5 therapeutic components
Pill B1-B5 is not taken, and instructions of taking is that once in the morning and once at night, 2 ball, boiled water take orally, observe after taking a period of time every time
Effect, compared with before medication, the label that symptom completely disappears is, the substantially reduced label of symptom is, symptom is without obviously changing
Kind label is that the therapeutic effect of 5 treatment groups is as illustrated in tables 5-6;Paste C1-C5 takes respectively in other 5 treatment groups, clothes
It is once in the morning and once at night one piece every time with method, boiled water is oral, observing effect after a period of time is taken, compared with before medication,
The label that symptom completely disappears is that the substantially reduced label of symptom is that the label that symptom is not improved is 5 treatments
The therapeutic effect of group is as shown in 5-6.
After table 5 takes 30
After table 6 takes 90
(3) to dysphoria in chestpalms-soles, dry throat therapeutic effect
Dysphoria in chestpalms-soles, dry throat 16-55 years old patient of 400 tools is selected, (every group 40 of 10 treatment groups are randomly divided into
People).Paste B1-B5 takes respectively in 5 treatment groups, and instructions of taking is once in the morning and once at night one piece every time, and boiled water is oral, clothes
With observing effect after a period of time, compared with before medication, the label that symptom completely disappears is, the substantially reduced label of symptom be
Δ, the label that symptom is not improved are that the therapeutic effect of 5 treatment groups is as shown in table 7-8;Other 5 treatment groups difference
Paste C1-C5 is taken, instructions of taking is once in the morning and once at night one piece every time, and boiled water is oral, observes effect after taking a period of time
Fruit, compared with before medication, the label that symptom completely disappears is, the substantially reduced label of symptom is, what symptom was not improved
Labeled as ×, the therapeutic effect of 5 treatment groups is as shown in table 7-8.
After table 7 takes 30
After table 8 takes 60
From the measurement result of the above experimental example can be seen that Chinese materia medica preparation provided by the invention for treat it is absent-minded,
Attention can not be concentrated, melancholy does not determine, haves the fidgets, sound logical miss, narration is unclear, the soreness of waist is passed out semen, sour with waist lower limb are seen
It is tired feel cold, be dysphoria in chestpalms-soles, the therapeutic effect of the symptoms such as dry throat and dry throat it is good, Chinese materia medica preparation provided by the invention can
To be effectively improved sleep quality, refreshment and tranquilization promotes blood oxygen, blood lipid metabolism.
The preferred embodiment of the present invention has been described above in detail, still, during present invention is not limited to the embodiments described above
Detail within the scope of the technical concept of the present invention can be with various simple variants of the technical solution of the present invention are made, this
A little simple variants all belong to the scope of protection of the present invention.
It is further to note that specific technical features described in the above specific embodiments, in not lance
In the case where shield, can be combined in any appropriate way, in order to avoid unnecessary repetition, the present invention to it is various can
No further explanation will be given for the combination of energy.
In addition, various embodiments of the present invention can be combined randomly, as long as it is without prejudice to originally
The thought of invention, it should also be regarded as the disclosure of the present invention.
Claims (10)
1. a kind of Chinese medicine composition, which is characterized in that the Chinese medicine composition contains following raw material: hollyhock essence, black hyacinth bean, uncaria,
Rhizoma Gastrodiae, peach kernel, safflower, fushen, Radix Polygalae, amber, rhizoma acori graminei, goldleaf, fructus alpiniae oxyphyllae, semen ziziphi spinosae, fructus schisandrae, lotus nut, walnut kernel,
Cape jasmine, sweet wormwood, humus flava usta, Radix Glycyrrhizae, wherein the total weight of the Chinese medicine composition relative to 100 parts by weight, the hollyhock essence
Content be 3-15 parts by weight, the content of black hyacinth bean is 3-15 parts by weight, the content of uncaria is 3-15 parts by weight, the content of Rhizoma Gastrodiae
For 2-12 parts by weight, the content of peach kernel be 2-12 parts by weight, the content of safflower is 2-12 parts by weight, the content of fushen is 2-12 weight
Amount part, Radix Polygalae content be 2-10 parts by weight, the content of amber is 2-10 parts by weight, the content of rhizoma acori graminei be 0.5-8 parts by weight,
The content of goldleaf is 0.01-0.05 parts by weight, the content of fructus alpiniae oxyphyllae is 2-10 parts by weight, the content of semen ziziphi spinosae is 2-10 weight
Part, the content of fructus schisandrae be 2-10 parts by weight, the content of lotus nut is 2-10 parts by weight, the content of walnut kernel is 2-10 weight
Part, the content of cape jasmine be 0.5-7 parts by weight, the content of sweet wormwood is 0.3-6 parts by weight, the content of humus flava usta be 0.5-7 parts by weight,
The content of Radix Glycyrrhizae is 0.3-6 parts by weight.
2. Chinese medicine composition according to claim 1, wherein the Chinese medicine composition relative to 100 parts by weight it is total
Weight, the content of the hollyhock essence is 5-12 parts by weight, the content of black hyacinth bean is 5-12 parts by weight, the content of uncaria is 5-12 weight
Measure part, the content of Rhizoma Gastrodiae is 3-10 parts by weight, the content of peach kernel is 3-10 parts by weight, the content of safflower is 3-10 parts by weight, Fu
The content of mind is 3-10 parts by weight, the content of Radix Polygalae is 3-8 parts by weight, the content of amber is 3-8 parts by weight, the content of rhizoma acori graminei
It for 1-5.5 parts by weight, the content of goldleaf is 0.01-0.03 parts by weight, the content of fructus alpiniae oxyphyllae is that 3-8 parts by weight, semen ziziphi spinosae contain
Amount is 3-8 parts by weight, the content of fructus schisandrae is 3-8 parts by weight, the content of lotus nut is 3-8 parts by weight, the content of walnut kernel is
3-8 parts by weight, the content of cape jasmine are 1-5 parts by weight, the content of sweet wormwood is 0.5-4 parts by weight, the content of humus flava usta is 1-5 weight
Part, the content of Radix Glycyrrhizae be 0.5-4 parts by weight.
3. Chinese medicine composition described in any one of -2 according to claim 1, wherein the raw material is powder, average particle size
For 150-200 mesh.
4. Chinese medicine composition described in any one of claim 1-3 is in preparation for improving sleep quality and substance in vivo generation
Thank to the application in the drug of obstacle.
5. Chinese medicine composition described in any one of claim 1-3 is in preparation for improving sleep quality and substance in vivo generation
Thank to the application in the food of obstacle.
6. a kind of Chinese materia medica preparation, which contains active constituent and auxiliary material, which is characterized in that the active constituent is right
It is required that Chinese medicine composition described in any one in 1-3.
7. Chinese materia medica preparation according to claim 6, wherein on the basis of the total weight of the Chinese materia medica preparation, it is described activity at
The content divided is 10-90 weight %, and the content of the auxiliary material is 10-90 weight %.
8. Chinese materia medica preparation according to claim 7, wherein the content of the active constituent is 40-60 weight %, described auxiliary
The content of material is 40-60 weight %.
9. the Chinese materia medica preparation according to any one of claim 6-8, wherein the auxiliary material includes pharmaceutically acceptable load
At least one of body, diluent, filler and bonding agent.
10. Chinese materia medica preparation described in any one of claim 6-9 is in preparation for improving sleep quality and substance in vivo metabolism
Application in the drug of obstacle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811547266.2A CN109432341A (en) | 2018-12-17 | 2018-12-17 | The application of Chinese medicine composition and Chinese materia medica preparation and they |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811547266.2A CN109432341A (en) | 2018-12-17 | 2018-12-17 | The application of Chinese medicine composition and Chinese materia medica preparation and they |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109432341A true CN109432341A (en) | 2019-03-08 |
Family
ID=65559465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811547266.2A Pending CN109432341A (en) | 2018-12-17 | 2018-12-17 | The application of Chinese medicine composition and Chinese materia medica preparation and they |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109432341A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748774A (en) * | 2005-10-20 | 2006-03-22 | 北京阜康仁生物制药科技有限公司 | Brain tonifying preparation and new preparing method |
CN103550532A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine (TCM) composition for treating palpitation |
CN105456582A (en) * | 2015-12-15 | 2016-04-06 | 赵乾锋 | Traditional Chinese medicine for treating depressive disorder and anxiety disorder |
CN107050364A (en) * | 2017-05-02 | 2017-08-18 | 李军 | It is a kind of to treat medicine of insomnia and preparation method thereof and application method |
-
2018
- 2018-12-17 CN CN201811547266.2A patent/CN109432341A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748774A (en) * | 2005-10-20 | 2006-03-22 | 北京阜康仁生物制药科技有限公司 | Brain tonifying preparation and new preparing method |
CN103550532A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine (TCM) composition for treating palpitation |
CN105456582A (en) * | 2015-12-15 | 2016-04-06 | 赵乾锋 | Traditional Chinese medicine for treating depressive disorder and anxiety disorder |
CN107050364A (en) * | 2017-05-02 | 2017-08-18 | 李军 | It is a kind of to treat medicine of insomnia and preparation method thereof and application method |
Non-Patent Citations (3)
Title |
---|
景秀香: "补脑丸治疗失眠健忘的疗效及安全性", 《中国当代医药》 * |
王丽: "当归健脑抗衰合剂治疗中风后抑郁症疗效观察", 《中西医结合心脑血管病杂志》 * |
金熙胜等: "针灸配合中药治疗不寐证33例", 《实用中医内科杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
CN103652361A (en) | Feed for postpartum sow in lactation period of 1-20 days and preparation method thereof | |
CN104799115A (en) | Chicken compound feed and preparation method thereof | |
CN106035861A (en) | Inonotus obliquus substitutional tea with health-care functions and preparation method thereof | |
CN104367879A (en) | Pharmaceutical composition for chickens' internal lesion caused by overexertion and preparation method of pharmaceutical composition | |
CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
CN104305205B (en) | A kind of Semen Cuscutae oral liquid improving immunity and preparation method thereof | |
CN103690919A (en) | Medicine for treating piglet iron-deficiency anemia and preparation method of medicine | |
CN104208581A (en) | Schisandra chinensis health care oral liquid capable of preventing alcoholic liver and preparation method thereof | |
KR101826737B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
CN102579896B (en) | Natural Chinese herbal medicine anticancer pill | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
CN106215118A (en) | Antineoplastic health preparation and preparation method thereof | |
TW202330006A (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
CN103933538A (en) | Medicine for treating spleen-kidney yang deficiency type cirrhosis ascites and preparation method thereof | |
CN109224021A (en) | Treat diabetes, the health protecting tea of lowering blood pressure and blood fat and preparation method | |
KR20120024186A (en) | A composition of health supplementary food and method thereof | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN109432341A (en) | The application of Chinese medicine composition and Chinese materia medica preparation and they | |
CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
CN104206597B (en) | A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof | |
CN109170052A (en) | A kind of dendrobium nobile stomach-nourishing health tea and preparation method thereof | |
CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
CN107034094A (en) | A kind of preparation method of channels sootheing and network vessel quickening bee honey health-care wine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190308 |
|
RJ01 | Rejection of invention patent application after publication |